TMEM259 and Alzheimer disease: Further, we examined membralin expression in human postmortem brain tissue by immunostaining, and observed a marked reduction in membralin staining intensity in AD patient samples (n = 7) compared to the non-AD control (n = 7) (Fig. 5c).